• Advait

  Form: powder and solvent for injection solution

  Active substance	Dosage
  recombinant human blood coagulation factor VIII octocog alfa	250 IU

  ATC code: B02BD02

  Manufacturer: Baxter Belgium Manufacturing SA (secondary packaging of finished medicinal product and solvent, partial quality control of finished medicinal product, batch release of finished medicinal product and solvent)

• Advait

  Form: powder and solvent for injection solution

  Active substance	Dosage
  recombinant human blood coagulation factor VIII octocog alfa	500 IU

  ATC code: B02BD02

  Manufacturer: Baxter Belgium Manufacturing SA (secondary packaging of finished medicinal product and solvent, partial quality control of finished medicinal product, batch release of finished medicinal product and solvent)

• Advait

  Form: powder and solvent for injection solution

  Active substance	Dosage
  recombinant human blood coagulation factor VIII octocog alfa	1000 IU

  ATC code: B02BD02

  Manufacturer: Baxter Belgium Manufacturing SA (secondary packaging of finished medicinal product and solvent, partial quality control of finished medicinal product, batch release of finished medicinal product and solvent)

• Advait

  Form: powder and solvent for injection solution

  Active substance	Dosage
  recombinant human blood coagulation factor VIII octocog alfa	1500 IU

  ATC code: B02BD02

  Manufacturer: Baxter Belgium Manufacturing SA (secondary packaging of finished medicinal product and solvent, partial quality control of finished medicinal product, batch release of finished medicinal product and solvent)

• Advait

  Form: powder and solvent for injection solution

  Active substance	Dosage
  recombinant human blood coagulation factor VIII octocog alfa	2000 IU

  ATC code: B02BD02

  Manufacturer: Baxter Belgium Manufacturing SA (secondary packaging of finished medicinal product and solvent, partial quality control of finished medicinal product, batch release of finished medicinal product and solvent)

• Advait

  Form: powder and solvent for injection solution

  Active substance	Dosage
  recombinant human blood coagulation factor VIII octocog alfa	3000 IU

  ATC code: B02BD02

  Manufacturer: Baxter Belgium Manufacturing SA (secondary packaging of finished medicinal product and solvent, partial quality control of finished medicinal product, batch release of finished medicinal product and solvent)

• Beriata

  Form: powder and solvent for solution for injection or infusion

  Active substance	Dosage
  human blood coagulation factor VIII	500 IU

  ATC code: B02BD02

  Manufacturer: CSL Behring GmbH (secondary packaging, batch release; manufacturing, primary packaging, quality control)

• Beriate

  Form: powder and solvent for solution for injection or infusion

  Active substance	Dosage
  human blood coagulation factor VIII	250 IU

  ATC code: B02BD02

  Manufacturer: CSL Behring GmbH (secondary packaging, batch release; manufacturing, primary packaging, quality control)

• Beriate

  Form: powder and solvent for solution for injection or infusion

  Active substance	Dosage
  human blood coagulation factor VIII	1000 IU

  ATC code: B02BD02

  Manufacturer: CSL Behring GmbH (secondary packaging, batch release; manufacturing, primary packaging, quality control)

• Emoclot

  Form: powder and solvent for infusion solution

  Active substance	Dosage
  human blood coagulation factor VIII	500 IU

  ATC code: B02BD02

  Manufacturer: Kedrion S.p.A.

• Emoclot

  Form: powder and solvent for infusion solution

  Active substance	Dosage
  human blood coagulation factor VIII	1000 IU

  ATC code: B02BD02

  Manufacturer: Kedrion S.p.A.

• Esperoct

  Form: powder and solvent for injection solution

  Active substance	Dosage
  Turoctocog alfa pegol	500 IU

  ATC code: B02BD02

  Manufacturer: A/S Novo Nordisk (responsible for batch release of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product, addition of scale to injection pen, labeling and secondary packaging of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product)

• Esperoct

  Form: powder and solvent for injection solution

  Active substance	Dosage
  Turoctocog alfa pegol	1000 IU

  ATC code: B02BD02

  Manufacturer: A/S Novo Nordisk (responsible for batch release of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product, addition of scale to injection pen, labeling and secondary packaging of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product)

• Esperoct

  Form: powder and solvent for injection solution

  Active substance	Dosage
  Turoctocog alfa pegol	1500 IU

  ATC code: B02BD02

  Manufacturer: A/S Novo Nordisk (responsible for batch release of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product, addition of scale to injection pen, labeling and secondary packaging of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product)

• Esperoct

  Form: powder and solvent for injection solution

  Active substance	Dosage
  Turoctocog alfa pegol	2000 IU

  ATC code: B02BD02

  Manufacturer: A/S Novo Nordisk (responsible for batch release of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product, addition of scale to injection pen, labeling and secondary packaging of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product)

• Esperoct

  Form: powder and solvent for injection solution

  Active substance	Dosage
  Turoctocog alfa pegol	3000 IU

  ATC code: B02BD02

  Manufacturer: A/S Novo Nordisk (responsible for batch release of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product, addition of scale to injection pen, labeling and secondary packaging of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product)

• Novoeight

  Form: powder for injection solution

  Active substance	Dosage
  turoctocog alfa	250 IU

  ATC code: B02BD02

  Manufacturer: A/S Novo Nordisk (preparation, filling in primary packaging, lyophilization and testing of finished medicinal product, quality control (microbiological testing) of finished medicinal product; quality control of finished medicinal product; labeling and secondary packaging of finished medicinal product, addition of scale to injection syringe); responsible for batch release of finished medicinal product

• Novoeight

  Form: powder for injection solution

  Active substance	Dosage
  turoctocog alfa	500 IU

  ATC code: B02BD02

  Manufacturer: A/S Novo Nordisk (preparation, filling in primary packaging, lyophilization and testing of finished medicinal product, quality control (microbiological testing) of finished medicinal product; quality control of finished medicinal product; labeling and secondary packaging of finished medicinal product, addition of scale to injection syringe); responsible for batch release of finished medicinal product

• Novoeight

  Form: powder for injection solution

  Active substance	Dosage
  turoctocog alfa	1000 IU

  ATC code: B02BD02

  Manufacturer: A/S Novo Nordisk (preparation, filling in primary packaging, lyophilization and testing of finished medicinal product, quality control (microbiological testing) of finished medicinal product; quality control of finished medicinal product; labeling and secondary packaging of finished medicinal product, addition of scale to injection syringe); responsible for batch release of finished medicinal product

• Novoeight

  Form: powder for injection solution

  Active substance	Dosage
  turoctocog alfa	3000 IU

  ATC code: B02BD02

  Manufacturer: A/S Novo Nordisk (preparation, filling in primary packaging, lyophilization and testing of finished medicinal product, quality control (microbiological testing) of finished medicinal product; quality control of finished medicinal product; labeling and secondary packaging of finished medicinal product, addition of scale to injection syringe); responsible for batch release of finished medicinal product

• Novojet

  Form: powder for injection solution

  Active substance	Dosage
  turoctocog alfa	1500 IU

  ATC code: B02BD02

  Manufacturer: A/S Novo Nordisk (preparation, filling in primary packaging, lyophilization and testing of finished medicinal product, quality control (microbiological testing) of finished medicinal product; quality control of finished medicinal product; labeling and secondary packaging of finished medicinal product, addition of scale to injection syringe); responsible for batch release of finished medicinal product

• Novojet

  Form: powder for injection solution

  Active substance	Dosage
  turoctocog alfa	2000 IU

  ATC code: B02BD02

  Manufacturer: A/S Novo Nordisk (preparation, filling in primary packaging, lyophilization and testing of finished medicinal product, quality control (microbiological testing) of finished medicinal product; quality control of finished medicinal product; labeling and secondary packaging of finished medicinal product, addition of scale to injection syringe); responsible for batch release of finished medicinal product

• Nuvik / nuwiq®

  Form: powder and solvent for injection solution

  Active substance	Dosage
  simoctocog alfa	500 IU

  ATC code: B02BD02

  Manufacturer: Octapharma AB (manufacturer responsible for manufacturing in bulk, primary packaging, visual inspection, integrity testing, quality testing, batch release of the final product (powder for solution for injection and solvent))

• Nuvik / nuwiq®

  Form: powder and solvent for injection solution

  Active substance	Dosage
  simoctocog alfa	1000 IU

  ATC code: B02BD02

  Manufacturer: Octapharma AB (manufacturer responsible for manufacturing in bulk, primary packaging, visual inspection, integrity testing, quality testing, batch release of the final product (powder for solution for injection and solvent))

• Nuvik / nuwiq®

  Form: powder and solvent for injection solution

  Active substance	Dosage
  simoctocog alfa	1500 IU

  ATC code: B02BD02

  Manufacturer: Octapharma AB (manufacturer responsible for manufacturing in bulk, primary packaging, visual inspection, integrity testing, quality testing, batch release of the final product (powder for solution for injection and solvent))

• Nuvik / nuwiq®

  Form: powder and solvent for injection solution

  Active substance	Dosage
  simoctocog alfa	2500 IU

  ATC code: B02BD02

  Manufacturer: Octapharma AB (manufacturer responsible for manufacturing in bulk, primary packaging, visual inspection, integrity testing, quality testing, batch release of the final product (powder for solution for injection and solvent))

• Nuwik / nuwiq®

  Form: powder and solvent for injection solution

  Active substance	Dosage
  simoctocog alfa	250 IU

  ATC code: B02BD02

  Manufacturer: Octapharma AB (manufacturer responsible for manufacturing in bulk, primary packaging, visual inspection, integrity testing, quality testing, batch release of the final product (powder for solution for injection and solvent))

• Nuwik / nuwiq®

  Form: powder and solvent for injection solution

  Active substance	Dosage
  simoctocog alfa	2000 IU

  ATC code: B02BD02

  Manufacturer: Octapharma AB (manufacturer responsible for manufacturing in bulk, primary packaging, visual inspection, integrity testing, quality testing, batch release of the final product (powder for solution for injection and solvent))

• Nuwik / nuwiq®

  Form: powder and solvent for injection solution

  Active substance	Dosage
  simoctocog alfa	3000 IU

  ATC code: B02BD02

  Manufacturer: Octapharma AB (manufacturer responsible for manufacturing in bulk, primary packaging, visual inspection, integrity testing, quality testing, batch release of the final product (powder for solution for injection and solvent))

• Nuwik / nuwiq®

  Form: powder and solvent for injection solution

  Active substance	Dosage
  simoctocog alfa	4000 IU

  ATC code: B02BD02

  Manufacturer: Octapharma AB (manufacturer responsible for manufacturing in bulk, primary packaging, visual inspection, integrity testing, quality testing, batch release of the final product (powder for solution for injection and solvent))

• Octanat

  Form: powder for injection solution

  Active substance	Dosage
  human blood coagulation factor VIII	1000 IU

  ATC code: B02BD02

  Manufacturer: Octapharma AB (manufacturing through the full cycle except secondary packaging)

• Octanate

  Form: powder for injection solution

  Active substance	Dosage
  human blood coagulation factor VIII	250 IU or 500 IU

  ATC code: B02BD02

  Manufacturer: Octapharma AB (manufacturing through the full cycle except secondary packaging)

• Refacto af

  Form: lyophilisate for solution for injection

  Active substance	Dosage
  moroctocog alfa	250 IU

  ATC code: B02BD02

  Manufacturer: Vayet Pharma S.A. (production of lyophilizate in full cycle; quality control of solvent (except piston friction force testing), secondary packaging of solvent into a set with the drug; responsible for batch release)

• Refacto af

  Form: lyophilisate for solution for injection

  Active substance	Dosage
  moroctocog alfa	500 IU

  ATC code: B02BD02

  Manufacturer: Vayet Pharma S.A. (production of lyophilizate in full cycle; quality control of solvent (except piston friction force testing), secondary packaging of solvent into a set with the drug; responsible for batch release)

• Refacto af

  Form: lyophilisate for solution for injection

  Active substance	Dosage
  moroctocog alfa	1000 IU

  ATC code: B02BD02

  Manufacturer: Vayet Pharma S.A. (production of lyophilizate in full cycle; quality control of solvent (except piston friction force testing), secondary packaging of solvent into a set with the drug; responsible for batch release)

• Refacto af

  Form: lyophilisate for solution for injection

  Active substance	Dosage
  moroctocog alfa	2000 IU

  ATC code: B02BD02

  Manufacturer: Vayet Pharma S.A. (production of lyophilizate in full cycle; quality control of solvent (except piston friction force testing), secondary packaging of solvent into a set with the drug; responsible for batch release)

• Refacto af

  Form: lyophilisate for solution for injection

  Active substance	Dosage
  moroctocog alfa	3000 IU

  ATC code: B02BD02

  Manufacturer: Vait Pharma S.A. (quality control at batch release and stability testing, labeling, secondary packaging, batch release)